US 7572448
Combined cancer treatment methods using selected antibodies to aminophospholipids
granted A61KA61K2039/505A61K39/395
Quick answer
US patent 7572448 (Combined cancer treatment methods using selected antibodies to aminophospholipids) held by The Board of Regents of the University of Texas System expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 73
- CPC classes
- A61K, A61K2039/505, A61K39/395, A61K39/39558, A61K47/62